VET is gaining major attention following a partnership with Franklin Templeton for RWA, securing an EU MiCAR license, and the Hayabusa protocol upgrade. The community is optimistic, discussing increased utility and potential for institutional adoption.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.